Wednesday, March 21, 2018 6:17:37 AM
Amphastar Pharmaceuticals announced that the U.S. Court for the District of Massachusetts entered final judgment in favor of Amphastar in a lawsuit brought by Momenta Pharmaceuticals and Sandoz. The District Court held that Amphastar is "the prevailing party" in the case and affirmed the jury verdict, dated July 21, 2017, holding that the claims of Momenta's U.S. patent are invalid because the claims are not enabled and lack written description.
The District Court also determined that Momenta and Sandoz had waived their ability to enforce the patent.
The District Court also denied Momenta's and Sandoz's motion to dismiss Amphastar's antitrust lawsuit relating to Momenta's and Sandoz's anticompetitive conduct before the USP and the District Court provided a schedule for the antitrust lawsuit with a jury trial set for September 9, 2019.
Read more at:
https://thefly.com/landingPageNews.php?id=2702058
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM